Clinical trials
Pemphigoid, Bullous trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 3 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 8 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Unknown status | 15 |
| Terminated | 7 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Approved for marketing | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CHU de Reims | 6 |
| University Hospital, Rouen | 5 |
| AKARI Therapeutics | 2 |
| Centre Hospitalier Universitaire de Nice | 2 |
| Chugai Pharmaceutical | 2 |
| Nihon Pharmaceutical Co., Ltd | 2 |
| Regeneron Pharmaceuticals | 2 |
| argenx | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Alkahest, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pemphigoid, Bullous | 62 |
| Pemphigus | 5 |
| Pruritus | 5 |
| Skin Diseases | 4 |
| Autoimmune Diseases | 3 |
| Blister | 3 |
| Antiphospholipid Syndrome | 2 |
| Behcet Syndrome | 2 |
| Dermatomyositis | 2 |
| Eosinophilia | 2 |
Trials
Showing 26 to 50 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.